|
Catalog Number 06437281160 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Consequences Or Impact To Patient (2199)
|
Event Date 10/04/2016 |
Event Type
malfunction
|
Manufacturer Narrative
|
(b)(4).
|
|
Event Description
|
The customer questioned results for 1 patient tested for elecsys tsh assay (tsh), elecsys ft4 ii assay (ft4 ii), elecsys pth immunoassay (pth) and triiodothyronine (t3) that showed different results using 3 different testing methods.The customer thinks there is an interference with the roche reagents.The high ft4 ii result is what made the customer investigate other thyroid results for this patient.The tsh result was normal and the elevated ft4 ii result did not match the patient¿s diagnosis since the patient does not have hypothyroidism.Three different samples from the patient were sent to 3 different sites using various testing methods.Based on the data provided, the results for tsh, ft4 ii and elecsys ft3 iii (ft3 iii) were erroneous and reported outside of the laboratory.This medwatch will cover ft4 ii.Refer to medwatch with patient identifier (b)(6) for information on the tsh erroneous results and medwatch with patient identifier (b)(6) for information on the ft3 iii erroneous results.Refer to the attached data for patient results.No adverse event occurred.The cobas 6000 e 601 module serial number was (b)(4).
|
|
Manufacturer Narrative
|
A specific root cause could not be identified.A sample from the patient was requested for investigation but could not be provided.Based on the information available, a general reagent issue can most likely be excluded.An interference may be present in the sample, but this cannot be confirmed since the sample was not provided for investigation.
|
|
Manufacturer Narrative
|
The customer obtained a new sample from the patient on (b)(6) 2017 and ran thyroid tests on the cobas 6000 e 601 module at the customer site and also sent it out to an external laboratory using a siemens system.The customer thinks the results from the siemens method are correct.Based on the data provided, additional erroneous results were identified for elecsys tsh assay (tsh), elecsys ft4 ii assay (ft4 ii), t4 assay (t4), t3assay (t3) and pth immunoassay (pth).The erroneous results were reported outside of the laboratory.Relevant tests/lab data was updated.Refer to manufacturer report 1823260-2017-00260-00 for the erroneous t4 results.Refer to manufacturer report 1823260-2017-00261-00 for the erroneous t3 results.Refer to manufacturer report 1823260-2017-00262-00 for the erroneous pth results.The patient sample from (b)(6) 2017 was submitted for investigation.Upon further investigation of the patient sample, a streptavidin interference was confirmed.This most likely caused the high ft4 ii results.The reagent used to perform the tests contains streptavidin.This specific interference is addressed in product labeling.
|
|
Search Alerts/Recalls
|
|
|